全球腹股沟疝气器材市场 -2023-2030
市场调查报告书
商品编码
1374795

全球腹股沟疝气器材市场 -2023-2030

Global Inguinal Hernia Devices Market -2023-2030

出版日期: | 出版商: DataM Intelligence | 英文 186 Pages | 商品交期: 最快1-2个工作天内

价格

本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

概述

腹股沟疝气装置是用来促进疝气周围受伤组织癒合的医疗装置。这些设备用于腹股沟疝气修补术,这是一种将疝气隆起压回原位并加强腹壁薄弱部位的外科手术。腹股沟疝气装置通常由网状材料组成,并缝合、钉合或粘合在疝气周围的区域。

网状物中的孔允许组织生长到装置中,从而减少疝气復发或復发的机会。除了网状装置外,在腹股沟疝气修补手术中还可以使用缝线(缝线),有时还可以使用网状装置。

修復疝气的手术可以是开腹手术或腹腔镜手术,外科医师会确定哪种麻醉方式最适合病人。总的来说,腹股沟疝气装置是腹股沟疝气手术治疗的关键组成部分,它们可以帮助支撑受损组织并防止疝气復发。

市场动态:驱动因素与限制因素

腹股沟疝气修补术数量不断增加

腹股沟疝气修补术数量的增加是腹股沟疝气器材市场的主要驱动力。例如,根据美国外科医师学会2023 年报告,光是在美国每年就进行100 万例腹股沟疝气修补手术,全球估计每年进行超过2,000 万例此类手术,疝气修补术已成为最常进行的普通外科手术之一全球。

此外,该报告强调腹股沟疝气的发生率不断增加,显示对疝气修復方案的巨大需求。需求激增表明医疗设备製造商需要开发创新产品,例如腹部三维 (3D) 成像,使医生能够透过小切口进行手术,而不是传统开放性手术中的大切口,从而减少组织损伤、减少疼痛并加快患者术后恢復,从而满足对成功的疝气修復手术日益增长的需求。

市场动态:克制

与疝气设备相关的高成本以及监管机构的挑战可能是一个潜在的障碍,并对预测期内的全球腹股沟疝气设备市场产生重大影响。这些设备的高成本可能会限制欠发达地区获得治疗的机会,给医疗机构带来压力,并影响患者选择手术的决策。

严格的监管审批流程和合规成本可能会对希望进入市场或开发产品的公司造成障碍。持续疼痛、感染、疝气復发、沾黏、肠阻塞、补片相关问题等併发症可能会导致不满意,并需要额外的医疗介入。这不会影响医疗费用,但也会阻止一些人接受疝气修补手术。对于行业利益相关者来说,克服这些挑战对于促进市场成长至关重要。

目录

第 1 章:方法与范围

  • 研究方法论
  • 报告的研究目的和范围

第 2 章:定义与概述

第 3 章:执行摘要

  • 按类型分類的片段
  • 按产品分类的片段
  • 按年龄组别分類的片段
  • 手术程序片段
  • 最终使用者的片段
  • 按地区分類的片段

第 4 章:动力学

  • 影响因素
    • 司机
      • 腹股沟疝气修补术数量不断增加
    • 限制
      • 疝气装置的高成本以及监管机构带来的挑战
    • 机会
    • 影响分析

第 5 章:产业分析

  • 波特五力分析
  • 供应链分析
  • 定价分析
  • 监管分析
  • 俄乌战争影响分析
  • DMI 意见

第 6 章:COVID-19 分析

  • COVID-19 分析
    • 新冠疫情爆发前的情景
    • 新冠疫情期间的情景
    • 新冠疫情后的情景
  • COVID-19 期间的定价动态
  • 供需谱
  • 疫情期间政府与市场相关的倡议
  • 製造商策略倡议
  • 结论

第 7 章:按类型

  • 腹股沟斜疝
  • 腹股沟直疝
  • 双侧腹股沟疝气
  • 股疝

第 8 章:副产品

  • 疝气网片
  • 疝气固定装置
  • 疝气修补耗材

第 9 章:按年龄组

  • 儿科
  • 成人

第 10 章:透过手术程序

  • 开放性手术
  • 腹腔镜手术
  • 机器人辅助疝气修復
  • 非网格过程

第 11 章:最终用户

  • 医院
  • 门诊手术中心
  • 专科诊所
  • 其他的

第 12 章:按地区

  • 北美洲
    • 我们
    • 加拿大
    • 墨西哥
  • 欧洲
    • 德国
    • 英国
    • 法国
    • 义大利
    • 西班牙
    • 欧洲其他地区
  • 南美洲
    • 巴西
    • 阿根廷
    • 南美洲其他地区
  • 亚太
    • 中国
    • 印度
    • 日本
    • 澳洲
    • 亚太其他地区
  • 中东和非洲

第13章:竞争格局

  • 竞争场景
  • 市场定位/份额分析
  • 併购分析

第 14 章:公司简介

  • Olympus Corporation
    • 公司简介
    • 产品类型组合和描述
    • 财务概览
    • 主要进展
  • Johnson & Johnson
  • Sinolinks Medical Innovation, Inc.
  • Beijing Biosis Healing Biological Technology Co.,Ltd
  • Betatech Medical
  • Medtronic
  • WL Gore & Associates, Inc.
  • Dynamesh Inc.
  • Cousin Biotech
  • Cook Medical

第 15 章:附录

简介目录
Product Code: MD7311

Overview

Inguinal hernia devices are medical devices that are used to promote the healing of injured tissue around hernias. These devices are used in inguinal hernia repair, a surgical procedure that presses a hernia bulge back into position and reinforces the abdominal wall weakness. Inguinal hernia devices usually consist of mesh and are stitched, stapled, or glued across the area surrounding the hernia.

Pores in the mesh allow tissue to grow into the device, which reduces the chance of a hernia recurring or relapsing. In addition to mesh devices, sutures (stitches) and sometimes mesh may be utilized during inguinal hernia repair surgery.

The surgery to repair the hernia can be open or laparoscopic, and the surgeon will determine which type of anesthesia is best for the patient. Overall, inguinal hernia devices are a key component of the surgical treatment of inguinal hernias, and they can help to support damaged tissue and prevent the hernia from returning.

Market Dynamics: Drivers and Restraints

The increasing number of inguinal hernia repairs

The rising number of inguinal hernia repairs is a major driver of the inguinal hernia device market. For instance, according to the American College of Surgeons 2023 report, 1 million inguinal hernia repairs are performed annually in the U.S. alone and a global estimate exceeding 20 million such surgeries each year, hernia repair has become one of the most often performed general surgical procedures globally.

Furthermore, this report emphasizes the increasing occurrence of inguinal hernias, indicating a huge demand for hernia repair options. This spike in demand indicates the need for medical device manufacturers to develop innovative products such as three-dimensional (3D) imaging of the abdomen allowed doctors to perform surgery through small incisions rather than the huge incisions linked with traditional open surgery, leading to less tissue damage, less pain, and faster postoperative recovery for patients and thereby fulfilling the rising need for successful hernia repair procedures.

Market Dynamics: Restraint

The high cost associated with hernia devices and the challenges posed by regulatory bodies can be a potential barrier and have a significant impact on the global inguinal hernia device market over the forecast period. The high cost of these devices may limit access to treatment in under developed regions and put strain on healthcare facility and influence patients decision making when it comes to opting for surgery.

The strict regulatory approval processes and compliance costs can create obstacles for companies looking to enter the market or develop products. Complications such as persistent pain, infections, hernia recurrence, adhesions, bowel obstructions, mesh-related issuesand others can lead to dissatisfaction and necessitate additional medical interventions. This not affects healthcare costs but also discourages some individuals from undergoing hernia repair surgery. Overcoming these challenges is crucial for industry stakeholders in order to foster growth, in the market.

Segment Analysis

The global inguinal hernia device market is segmented based on type, product, age group, surgical procedure, end user and region.

The hernia mesh segment accounted for approximately 44.2 % of the market share

The hernia mesh segment accounted for 44.2% and it is expected to be dominated during the forecast period. The segment holds a position, in the market due to its usage and effectiveness in inguinal hernia repair procedures. These meshes offer support to weakened abdominal walls reducing the chances of hernia recurrence. They are available in materials and designs catering to the needs of patients. Additionally, rise of minimal invasive procedures has led to popularity due increasing number of surgeries has led to a higher demand, for hernia meshes as they work well with these procedures.

The increasing funding for the development of advanced mesh will create a positive impact on the market. For instance, in August 2022, Deep Blue Medical Advances, a Durham company previously funded with more than $400,000 in North Carolina Biotechnology Center loans, has raised more than $7 million in venture capital to facilitate development with the commercialization of its T-Line Hernia Mesh product. This innovative device intends to eliminate a common source of failure in conventional mesh fixation, reinforce anchors, and improve hernia repair procedures.

Furthermore, in February 2022, Dolphin Mesh, manufactured in India by Futura Surgicare Pvt Ltd, launched a premium surgical mesh brand built for "tension-free" and laparoscopic hernia repairs. These meshes serve as crucial devices in surgeries that strengthens weakened areas, enable tissue ingrowth, and may be modified to meet individual surgical demands. Thus, owing to the above factors the segment is expected to dominate over the forecast period.

Geographical Analysis

North America accounted for approximately 37.4% of the market share in 2022

North America is estimated to hold about 37.4% of the total market share throughout the forecast period, owing to the increasing number of investment, increasing prevalence of hernia, product approvals and FDA clearance, collaboration with the key players, and others that will drive this region further during the forecast period.

For instance, in October 2022, Medtronic plc, a prominent global healthcare technology business, received approvals for its Hugo robotic-assisted surgery (RAS) system, expanding its market reach and indications globally. Particulary, Health Canada has received a license for general laparoscopic surgery use. These approvals bring up new options for minimally invasive surgery in Europe, North America, and Asia, making the benefits more accessible globally. These treatments range from simple to sophisticated and include cholecystectomy, inguinal hernia repair, gastric bypass, and lower anterior resection.

Furthermore, in June 2023, Advanced Medical Solutions Group plc, a world leader in tissue-healing technologies, received the U.S. FDA approval for the Pre-Market Approval (PMA) of LiquiBandFix8 for use in hernia surgery. To secure mesh to tissue within the body during hernia surgery, LiquiBandFix8 uses droplets of cyanoacrylate adhesive rather than sharp tacks. To secure mesh to tissue within the body during hernia surgery, LiquiBandFix8 uses droplets of cyanoacrylate adhesive rather than sharp tacks. Thus, owing to the above factors the region is expected to dominate over the forecast period.

COVID-19 Impact Analysis

The COVID-19 pandemic has majorly impacted the market, as it has resulted in a significant decrease in the amount of elective hernia repairs, particularly incisional hernia surgery. For instance, according to British Journal of Surgery 2022 article, inguinal hernia is a common surgical disease in children, with a 6% to 16% frequency in preterm and low-birthweight infants. The COVID-19 pandemic impacted hospital services, but it also presented a unique opportunity to collect clinical outcomes for children with inguinal hernia who would face delays in operative therapy, including the chance of spontaneous resolution while awaiting operative repair.

During the COVID-19 pandemic, twenty-five UK pediatric surgical centers took part in observational research evaluating the therapy of inguinal hernia in infants under 6 months of age. The study discovered a substantial decrease in the frequency of inguinal hernia repairs performed during the pandemic compared to the same period in the previous year.

Competitive Landscape

The major global players in the inguinal hernia devices market include: B Braun Melsungen AG, Johnson & Johnson, Sinolinks Medical Innovation, Inc., Beijing Biosis Healing Biological Technology Co.,Ltd, Betatech Medical, Medtronic, W. L. Gore & Associates, Inc., Dynamesh Inc., Cousin Biotech, Cook Medical and among others.

Why Purchase the Report?

  • To visualize the global inguinal hernia devices market segmentation-based on type, product, age group, surgical procedure, end user and region as well as understand key commercial assets and players.
  • Identify commercial opportunities by analyzing trends and co-development
  • Excel data sheet with numerous data points of inguinal hernia devices market-level with all segments.
  • PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.
  • Product mapping available as Excel consisting of key products of all the major players.

The global inguinal hernia devices market report would provide approximately 79 tables, 79 figures, and 185 Pages.

Target Audience 2023

  • Manufacturers/ Buyers
  • Industry Investors/Investment Bankers
  • Research Professionals
  • Emerging Companies

Table of Contents

1. Methodology and Scope

  • 1.1. Research Methodology
  • 1.2. Research Objective and Scope of the Report

2. Definition and Overview

3. Executive Summary

  • 3.1. Snippet by Type
  • 3.2. Snippet by Product
  • 3.3. Snippet by Age Group
  • 3.4. Snippet by Surgical Procedure
  • 3.5. Snippet by End User
  • 3.6. Snippet by Region

4. Dynamics

  • 4.1. Impacting Factors
    • 4.1.1. Driver
      • 4.1.1.1. The increasing number of inguinal hernia repairs
    • 4.1.2. Restraints
      • 4.1.2.1. The high cost associated with hernia devices and the challenges posed by regulatory bodies
    • 4.1.3. Opportunity
    • 4.1.4. Impact Analysis

5. Industry Analysis

  • 5.1. Porter's Five Force Analysis
  • 5.2. Supply Chain Analysis
  • 5.3. Pricing Analysis
  • 5.4. Regulatory Analysis
  • 5.5. Russia-Ukraine War Impact Analysis
  • 5.6. DMI Opinion

6. COVID-19 Analysis

  • 6.1. Analysis of COVID-19
    • 6.1.1. Scenario Before COVID
    • 6.1.2. Scenario During COVID
    • 6.1.3. Scenario Post COVID
  • 6.2. Pricing Dynamics Amid COVID-19
  • 6.3. Demand-Supply Spectrum
  • 6.4. Government Initiatives Related to the Market During Pandemic
  • 6.5. Manufacturers Strategic Initiatives
  • 6.6. Conclusion

7. By Type

  • 7.1. Introduction
    • 7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
    • 7.1.2. Market Attractiveness Index, By Type
  • 7.2. Indirect Inguinal Hernia*
    • 7.2.1. Introduction
    • 7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 7.3. Direct Inguinal Hernia
  • 7.4. Bilateral Inguinal Hernia
  • 7.5. Femoral Hernia

8. By Product

  • 8.1. Introduction
    • 8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
    • 8.1.2. Market Attractiveness Index, By Product
  • 8.2. Hernia Meshes*
    • 8.2.1. Introduction
    • 8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 8.3. Hernia Fixation Devices
  • 8.4. Hernia Repair Consumables

9. By Age Group

  • 9.1. Introduction
    • 9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Age Group
    • 9.1.2. Market Attractiveness Index, By Age Group
  • 9.2. Pediatric*
    • 9.2.1. Introduction
    • 9.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 9.3. Adult

10. By Surgical Procedure

  • 10.1. Introduction
    • 10.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Surgical Procedure
    • 10.1.2. Market Attractiveness Index, By Surgical Procedure
  • 10.2. Open Surgery*
    • 10.2.1. Introduction
    • 10.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 10.3. Laparoscopic Surgery
  • 10.4. Robotic-assisted Hernia Repair
  • 10.5. Non-mesh Procedures

11. By End-users

  • 11.1. Introduction
    • 11.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-users
    • 11.1.2. Market Attractiveness Index, By End-users
  • 11.2. Hospitals*
    • 11.2.1. Introduction
    • 11.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 11.3. Ambulatory Surgical Centers
  • 11.4. Specialty Clinics
  • 11.5. Others

12. By Region

  • 12.1. Introduction
    • 12.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
    • 12.1.2. Market Attractiveness Index, By Region
  • 12.2. North America
    • 12.2.1. Introduction
    • 12.2.2. Key Region-Specific Dynamics
    • 12.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
    • 12.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
    • 12.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Age Group
    • 12.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Surgical Procedure
    • 12.2.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
    • 12.2.8. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 12.2.8.1. U.S.
      • 12.2.8.2. Canada
      • 12.2.8.3. Mexico
  • 12.3. Europe
    • 12.3.1. Introduction
    • 12.3.2. Key Region-Specific Dynamics
    • 12.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
    • 12.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
    • 12.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Age Group
    • 12.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Surgical Procedure
    • 12.3.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
    • 12.3.8. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 12.3.8.1. Germany
      • 12.3.8.2. UK
      • 12.3.8.3. France
      • 12.3.8.4. Italy
      • 12.3.8.5. Spain
      • 12.3.8.6. Rest of Europe
  • 12.4. South America
    • 12.4.1. Introduction
    • 12.4.2. Key Region-Specific Dynamics
    • 12.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
    • 12.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
    • 12.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Age Group
    • 12.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Surgical Procedure
    • 12.4.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
    • 12.4.8. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 12.4.8.1. Brazil
      • 12.4.8.2. Argentina
      • 12.4.8.3. Rest of South America
  • 12.5. Asia-Pacific
    • 12.5.1. Introduction
    • 12.5.2. Key Region-Specific Dynamics
    • 12.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
    • 12.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
    • 12.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Age Group
    • 12.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Surgical Procedure
    • 12.5.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
    • 12.5.8. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 12.5.8.1. China
      • 12.5.8.2. India
      • 12.5.8.3. Japan
      • 12.5.8.4. Australia
      • 12.5.8.5. Rest of Asia-Pacific
  • 12.6. Middle East and Africa
    • 12.6.1. Introduction
    • 12.6.2. Key Region-Specific Dynamics
    • 12.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
    • 12.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
    • 12.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Age Group
    • 12.6.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Surgical Procedure
    • 12.6.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User

13. Competitive Landscape

  • 13.1. Competitive Scenario
  • 13.2. Market Positioning/Share Analysis
  • 13.3. Mergers and Acquisitions Analysis

14. Company Profiles

  • 14.1. Olympus Corporation*
    • 14.1.1. Company Overview
    • 14.1.2. Product Type Portfolio and Description
    • 14.1.3. Financial Overview
    • 14.1.4. Key Developments
  • 14.2. Johnson & Johnson
  • 14.3. Sinolinks Medical Innovation, Inc.
  • 14.4. Beijing Biosis Healing Biological Technology Co.,Ltd
  • 14.5. Betatech Medical
  • 14.6. Medtronic
  • 14.7. W. L. Gore & Associates, Inc.
  • 14.8. Dynamesh Inc.
  • 14.9. Cousin Biotech
  • 14.10. Cook Medical

LIST NOT EXHAUSTIVE

15. Appendix

  • 15.1. About Us and Services
  • 15.2. Contact Us